Cargando…

Daratumumab in AL Amyloidosis: A Real-Life Experience of the “RTM” (Regional Tuscan Myeloma Network)

Systemic amyloidosis arises from monoclonal CD38+ plasma cells that produce misfolded immunoglobulin light chains, which form amyloid fibrils that are deposited into different tissues, leading to organ damage. Daratumumab is a human IgG/k monoclonal antibody that targets CD38, a glycoprotein uniform...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sammartano, Vincenzo, Antonioli, Elisabetta, Buda, Gabriele, Ciofini, Sara, Candi, Veronica, Pengue, Ludovica, Del Giudice, Maria Livia, Attucci, Irene, Bacchiarri, Francesca, Occhini, Ubaldo, Pirrotta, Maria Teresa, Perfetto, Federico, Bocchia, Monica, Gozzetti, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952680/ https://www.ncbi.nlm.nih.gov/pubmed/35330483 http://dx.doi.org/10.3390/jpm12030484

Ejemplares similares

P48 CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED REFRACTORY MULTIPLE MYELOMA: A PROSPECTIVE REAL-LIFE EXPERIENCE OF THE REGIONAL TUSCAN MYELOMA NETWORK (RTM)
por: Attucci, I., et al.
Publicado: (2023)

Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network
por: Antonioli, Elisabetta, et al.
Publicado: (2023)

Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients
por: Gozzetti, Alessandro, et al.
Publicado: (2020)

Carfilzomib plus dexamethasone in patients with relapsed and refractory multiple myeloma: A retro‐prospective observational study
por: Del Giudice, Maria Livia, et al.
Publicado: (2022)

Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study
por: Del Giudice, Maria Livia, et al.
Publicado: (2021)

A BRAF-Negative Classic Hairy Cell Leukemia Patient with Long-Lasting Complete Remission after Rituximab and Pentostatin
por: Gozzetti, Alessandro, et al.
Publicado: (2020)

Daratumumab efficacy in extramedullary orbital myeloma
por: Gozzetti, Alessandro, et al.
Publicado: (2020)

Anti-BCMA novel therapies for multiple myeloma
por: Sammartano, Vincenzo, et al.
Publicado: (2023)

Functional Imaging in the Evaluation of Treatment Response in Multiple Myeloma: The Role of PET-CT and MRI
por: Santoni, Adele, et al.
Publicado: (2022)

A case of bone lesion in a patient with relapsed chronic lymphocytic leukemia and review of the literature
por: Bacchiarri, Francesca, et al.
Publicado: (2022)

Role of Daratumumab in Cardiac AL Amyloidosis
por: Gertz, Morie A.
Publicado: (2022)

Therapeutic Advancements in Multiple Myeloma
por: Gozzetti, Alessandro, et al.
Publicado: (2014)

Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
por: Palladini, Giovanni, et al.
Publicado: (2021)

RTM-II : recomendaciones terapéuticas en los trastornos mentales
Publicado: (1999)

P22 THE PROGNOSTIC ROLE OF 1Q ABNORMALITIES IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
por: Attucci, I., et al.
Publicado: (2023)

Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications
por: Cencini, Emanuele, et al.
Publicado: (2023)

Systemic light chain amyloidosis myopathy responsive to daratumumab monotherapy
por: Chitimus, Diana Maria, et al.
Publicado: (2022)

The RTM Resistance to Potyviruses in Arabidopsis thaliana: Natural Variation of the RTM Genes and Evidence for the Implication of Additional Genes
por: Cosson, Patrick, et al.
Publicado: (2012)

Minimal Residual Disease in Multiple Myeloma: State of the Art and Applications in Clinical Practice
por: Gozzetti, Alessandro, et al.
Publicado: (2020)

Anti CD38 monoclonal antibodies for multiple myeloma treatment
por: Gozzetti, Alessandro, et al.
Publicado: (2022)

Galileo Galilei, the Tuscan artist
por: Greco, Pietro
Publicado: (2018)

Rabbit Tissue Model (RTM) Harvesting Technique
por: Medina, Marelyn
Publicado: (2002)

Drug resistance and minimal residual disease in multiple myeloma
por: Gozzetti, Alessandro, et al.
Publicado: (2022)

Rome in Winter, and the Tuscan Hills in Summer
Publicado: (1886)

Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T‐cell lymphoblastic leukemia
por: Zappone, Elisabetta, et al.
Publicado: (2020)

Intubation practice patterns in Tuscan emergency departments
por: Sanchez, Leon D., et al.
Publicado: (2008)

Bio-Functional Activities of Tuscan Bee Pollen
por: Chelucci, Elisa, et al.
Publicado: (2023)

Central Nervous System Myeloma and Unusual Extramedullary Localizations: Real Life Practical Guidance
por: Sammartano, Vincenzo, et al.
Publicado: (2022)

Genetic control of renal tumorigenesis by the mouse Rtm1 locus
por: Jensen, José Ricardo, et al.
Publicado: (2013)

Application of KNN and ANN Metamodeling for RTM Filling Process Prediction
por: Chai, Boon Xian, et al.
Publicado: (2023)

P17 CLONAL PLASMA-CELLS IN STEM CELL APHERESIS AS A PREDICTOR OF PROGRESSION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS ELEGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION
por: Pilerci, S., et al.
Publicado: (2023)

RTM, The DELPHI Read-out Timing Monitor (Description and Operating Instruction)
por: Bocci, V, et al.
Publicado: (1993)

M10.6.8: Integration of downconverters and upconverters in RTM (ATCA)
por: Czuba, K, et al.
Publicado: (2011)

The Effect of the Parameters of T-RTM on the Properties of Polyamide 6 Prepared by in Situ Polymerization
por: Semperger, Orsolya Viktória, et al.
Publicado: (2019)

Essay Illustrating the Tables of the Medical Statistics of the Tuscan Maremma
Publicado: (1846)

Steps towards a Multiple Myeloma Cure?
por: Gozzetti, Alessandro, et al.
Publicado: (2022)

Liquid biopsy and blood-based minimal residual disease evaluation in multiple myeloma
por: GOZZETTI, ALESSANDRO, et al.
Publicado: (2023)

T cell landscape and dynamics in immunoglobulin light chain amyloidosis before and after daratumumab‐based therapy
por: Wang, Yujia, et al.
Publicado: (2021)

Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis
por: Theodorakakou, Foteini, et al.
Publicado: (2021)

Usage of Near-Infrared Spectroscopy for Inline Monitoring the Degree of Curing in RTM Processes
por: Salzmann, Moritz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9i79ogqgrfttvnjm5e707ionv3